Skip to main content

Table 1 Demographic characteristics and baseline OAB/sexual scores of participants

From: The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study

Variable Group A Group B P value
Age (yr) 43.5 (10.0) 43 (10) 0.838
Body weight (kg) 59.0 (14.0) 55.0 (14.0) 0.406
Symptom duration (yr) 4.2 (1.5) 4.2 (3.3) 0.821
Parity 2.0 (2.0) 2.0 (1.0) 0.738
Frequency 11.0 (1.0) 11.0 (2.0) 0.213
Urgency episodes 6.5 (1.0) 7.0 (2.0) 0.303
Nocturia episodes 2.0 (1.0) 2.0 (1.0) 0.227
Incontinence episodes 2.0 (1.0) 2.0 (1.0) 0.287
Incontinence pads 5.0 (2.0) 4.0 (2.0) 0.838
Voided volume (ml) 121.5 (31.0) 117.0 (33.0) 0.725
Desire 3.0 (0.6) 3.0 (1.2) 0.411
Arousal 3.6 (0.6) 3.0 (0.8) 0.281
Lubrication 3.6 (0.9) 3.9 (1.1) 0.214
Orgasm 3.6 (0.4) 3.6 (0.8) 0.253
Satisfaction 3.2 (0.4) 3.2 (0.8) 0.099
Pain 3.2 (0.4) 3.2 (0.8) 0.068
Total Score of Sexual Function 20.0 (2.5) 20.3 (3.8) 0.355
\